Skip to content

Comparing the blood test values in critically infectious patients

COMPARISON OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) VS PROCALCITONIN AS A PROGNOSTIC MARKER OF SEPSIS IN INTENSIVE CARE UNIT - AN OBSERVATIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079190
Enrollment
50
Registered
2025-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A499- Bacterial infection, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

All India Institute of Medical Sciences, Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged more than 18 years and less than 60 years. Patients with suspected sepsis or septic shock exhibiting two or more of the following signs during their first 24 hours in the ICU: temperature more than 38 degree C, heart rate more than 90 beats per min, respiratory rate more than 20 breathsper min with partial pressure of arterial carbon dioxide less than 32 mmHg, and white blood cell count more than 12,000 cells per mm3.

Exclusion criteria

Exclusion criteria: Age less than 18 years Patients with terminal stage of disease (malignant cancer of any type, acquired immunodeficiency syndrome, end-stage liver or renal disease). On long term steroids/ Immunosuppressants/ Chemotherapy Neutropenic patients Patients with HIV Patients who were expected to have a short-term (less than 72 hours) intensive care treatment

Design outcomes

Primary

MeasureTime frame
The primary objective is to compare the prognostic value of suPAR vs Procalcitonin in patients with sepsis and septic shockTimepoint: During admission to the ICU (prior to therapeutic interventions) as well as in the morning of Day 7 after admission.

Secondary

MeasureTime frame
1. To define an optimum cut-off value of suPAR for diagnosing sepsis and predicting mortality. 2. To compare the the diagnostic accuracy of suPAR with procalcitonin for diagnosis of sepsis and septic shock in critically ill patients. 3. To observe an association between suPAR and duration of ICU stay, ventilator days, dialysis days. Timepoint: During admission to the ICU (prior to therapeutic interventions) as well as in the morning of Day 7 after admission.

Countries

India

Contacts

Public ContactDr Revathi Abarna P K

AIIMS Jodhpur

drnikhilkothari@gmail.com8003996948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026